Cerevast Therapeutics' Series C - II Round

Cerevast Therapeutics raised a round of funding on April 22, 2013. Investors include Genstar Capital Partners.

Cerevast Therapeutics is developing a non-invasive treatment for acute ischemic stroke known as sonothrombolysis, or SonoLysis for short. This treatment harnesses the acoustic energy from externally a…

Articles about Cerevast Therapeutics' Series C - II Round: